Infectious Diseases
From the Journals
All-oral regimen succeeds for rifampin-resistant tuberculosis
Safety and effectiveness of a bedaquiline, pretomanid, and linezolid combination supports its use as a first-line treatment for adolescents and...
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
Opinion
Is air filtration the best public health intervention against respiratory viruses?
The idea is that those ions stick to the virus particles ... and that tends to cause them to clump together and settle on surfaces more rapidly,...
Conference Coverage
Chest pain with long COVID common but undertreated
“Our current analysis indicates that chest pain continues on for years in many individuals, suggesting that COVID-related chest pain may be...
From the Journals
Intense exercise may lead to colds. A new study tells us why
“Physicians can use this study’s findings to provide individualized exercise recommendations.”
From the Journals
Childhood immunization schedule includes new RSV, mpox, meningococcal, and pneumococcal vaccines
Experts say the updates are timely and necessary, while noting that pediatricians should become familiar with the changes to discuss the topic...
Feature
Breast implants used in double lung transplant post infection
Lungs ravaged by disease and infection were removed, and breast implants used to hold heart in place while awaiting transplant.
Conference Coverage
Saltwater gargling may help avoid COVID hospitalization
Hospitalization rates in the low- (18.5%) and high- (21.4%) saline groups were significantly lower than in the reference control population.
From the Journals
People with long COVID don’t show signs of brain damage
“The findings thus suggest that post-COVID condition is not the result of ongoing infection, immune activation, or brain damage.”
From the Journals
ACORN: No excess AKI with pip-tazo vs. cefepime
Results of the randomized trial suggest that clinicians can safely prescribe empiric piperacillin-tazobactam for serious acute infections.